APP and Alzheimer disease: Similarly, multiple treatments of APP/PS1 mice as an AD animal model with BDNF + ADTC5 significantly improved the cognitive abilities of mice compared to controls such as PBS- and BDNF-treated mice when evaluated using novel object recognition and Y-maze [41].